Pediatric Dosing of Metoclopramide
For pediatric patients, metoclopramide dosing is age and indication-dependent: children under 6 years receive 0.1 mg/kg, children 6-14 years receive 2.5-5 mg, and those over 14 years receive the adult dose of 10 mg. 1
Weight-Based Dosing by Age Group
Infants and Young Children (Under 6 Years)
- Standard dose: 0.1 mg/kg per dose 1
- This dose can be administered IV, IM, or orally every 6 hours 2, 3
- Critical caveat: In infants less than 1 month of age, use extreme caution as prolonged clearance may produce excessive serum concentrations and drug accumulation 3
- The youngest infants (3.5 weeks) demonstrated elimination half-lives of 23.1 hours after initial dosing, which decreased to 10.3 hours at steady state 3
Children 6-14 Years
- Dose range: 2.5-5 mg per dose 1
- For prevention of postoperative nausea/vomiting, 0.25 mg/kg IV has demonstrated superior efficacy compared to lower doses 4
- The 0.25 mg/kg dose reduced vomiting incidence to 29% versus 88% in controls and 68% with the 0.15 mg/kg dose 4
Adolescents (Over 14 Years) and Adults
- Standard dose: 10 mg per dose 1
- Maximum single dose should not exceed 10 mg for routine indications 1
Route-Specific Considerations
Intravenous Administration
- Administer slowly over 1-2 minutes for single doses 1
- For chemotherapy-related nausea: infuse over at least 15 minutes 1
- Higher doses (2 mg/kg) for highly emetogenic chemotherapy should be diluted in 50 mL parenteral solution 1
Oral Administration
- Bioavailability is approximately 80% 1
- Time to peak concentration averages 2.0-2.2 hours in infants 3
- A dose of 0.15 mg/kg orally every 6 hours produces therapeutic exposures in most pediatric patients, though slightly lower exposures occur in children under 2 years 5
Indication-Specific Dosing
Facilitating Small Bowel Intubation
Prevention of Postoperative Nausea/Vomiting
- Optimal dose: 0.25 mg/kg IV (not 0.15 mg/kg) 4
- Administer immediately after induction of anesthesia 4
- This higher dose (0.25 mg/kg) is as effective as droperidol and reduces hospital stay by approximately 45-60 minutes compared to placebo 4
Gastroesophageal Reflux
- Recommended dose: 0.15 mg/kg orally every 6 hours 2, 3
- Produces steady-state concentrations of 32.7-56.2 ng/mL 3
- Results in 75% reduction in reflux time in responsive patients 3
Renal Impairment Adjustments
- When creatinine clearance is below 40 mL/min, initiate therapy at approximately one-half the recommended dosage 1
- Renal impairment correlates with reduced plasma clearance and increased elimination half-life 1
- Dosage may be adjusted based on clinical efficacy and safety 1
Safety Considerations
Extrapyramidal Symptoms
- If acute dystonic reactions occur, administer 50 mg diphenhydramine IM 1
- Risk appears minimal at standard doses, with only isolated case reports in large systematic reviews 6
Age-Related Pharmacokinetic Differences
- Neonates and young infants demonstrate 1.4-fold higher apparent clearance and 2.1-fold higher volume of distribution compared to adults 2
- Pharmacokinetics exhibit developmental dependency, with immature hepatic and renal systems at birth causing prolonged half-life 1, 3
- No significant correlation exists between gestational, postnatal, or postconceptional age and pharmacokinetic parameters beyond the neonatal period 2
Common Pitfall to Avoid
Do not use the 0.15 mg/kg dose for postoperative nausea/vomiting prophylaxis—this dose showed a 68% vomiting incidence versus 29% with 0.25 mg/kg 4. The higher dose is necessary for adequate antiemetic effect in the surgical setting, while the lower dose is appropriate for gastroesophageal reflux treatment.